181 related articles for article (PubMed ID: 29170639)
21. Critical Analysis of Neuronal Cell and the Mouse Bioassay for Detection of Botulinum Neurotoxins.
Pellett S; Tepp WH; Johnson EA
Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31817843
[TBL] [Abstract][Full Text] [Related]
22. Botulinum neurotoxin A and an engineered derivate targeted secretion inhibitor (TSI) A enter cells via different vesicular compartments.
Fonfria E; Donald S; Cadd VA
J Recept Signal Transduct Res; 2016; 36(1):79-88. PubMed ID: 26329879
[TBL] [Abstract][Full Text] [Related]
23. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
Shone CC; Roberts AK
Eur J Biochem; 1994 Oct; 225(1):263-70. PubMed ID: 7925446
[TBL] [Abstract][Full Text] [Related]
24. Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.
Purkiss JR; Friis LM; Doward S; Quinn CP
Neurotoxicology; 2001 Aug; 22(4):447-53. PubMed ID: 11577803
[TBL] [Abstract][Full Text] [Related]
25. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
Dolimbek BZ; Jankovic J; Atassi MZ
Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
27. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
[TBL] [Abstract][Full Text] [Related]
28. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.
Nakamura K; Kohda T; Shibata Y; Tsukamoto K; Arimitsu H; Hayashi M; Mukamoto M; Sasakawa N; Kozaki S
Infect Immun; 2012 Aug; 80(8):2886-93. PubMed ID: 22665374
[TBL] [Abstract][Full Text] [Related]
29. Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").
Pellett S; Tepp WH; Lin G; Johnson EA
Toxicon; 2018 Jun; 147():38-46. PubMed ID: 29273248
[TBL] [Abstract][Full Text] [Related]
30. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics.
Behrensdorf-Nicol HA; Wild E; Bonifas U; Klimek J; Hanschmann KM; Krämer B; Kegel B
Toxicol In Vitro; 2018 Dec; 53():80-88. PubMed ID: 30016653
[TBL] [Abstract][Full Text] [Related]
31. An in vitro assay for detection of tetanus neurotoxin activity: using antibodies for recognizing the proteolytically generated cleavage product.
Kegel B; Behrensdorf-Nicol HA; Bonifas U; Silberbach K; Klimek J; Krämer B; Weisser K
Toxicol In Vitro; 2007 Dec; 21(8):1641-9. PubMed ID: 17826026
[TBL] [Abstract][Full Text] [Related]
32. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro.
Ekong TAN; Feavers IM; Sesardic D
Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3337-3347. PubMed ID: 9353935
[TBL] [Abstract][Full Text] [Related]
33. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
Lawrence GW; Wang J; Brin MF; Aoki KR; Wheeler L; Dolly JO
FEBS J; 2014 Jul; 281(14):3243-60. PubMed ID: 24863955
[TBL] [Abstract][Full Text] [Related]
34. Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins.
Pathe-Neuschäfer-Rube A; Neuschäfer-Rube F; Haas G; Langoth-Fehringer N; Püschel GP
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30189643
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
Kalb SR; Baudys J; Raphael BH; Dykes JK; Lúquez C; Maslanka SE; Barr JR
Anal Chem; 2015 Apr; 87(7):3911-7. PubMed ID: 25731972
[TBL] [Abstract][Full Text] [Related]
36. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
37. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
[TBL] [Abstract][Full Text] [Related]
38. Development of an in vitro activity assay as an alternative to the mouse bioassay for Clostridium botulinum neurotoxin type A.
Rasooly R; Do PM
Appl Environ Microbiol; 2008 Jul; 74(14):4309-13. PubMed ID: 18515481
[TBL] [Abstract][Full Text] [Related]
39. Clostridium botulinum neurotoxin type B is heat-stable in milk and not inactivated by pasteurization.
Rasooly R; Do PM
J Agric Food Chem; 2010 Dec; 58(23):12557-61. PubMed ID: 21053906
[TBL] [Abstract][Full Text] [Related]
40. Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes.
Sharma SK; Basavanna U; Shukla HD
Toxins (Basel); 2010 Jan; 2(1):1-9. PubMed ID: 22069543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
